市场调查报告书
商品编码
1494869
到 2030 年造影数位乳房X光摄影(CEDM) 市场预测:按影像类型、技术、应用、最终用户和地区进行的全球分析Contrast Enhanced Digital Mammography (CEDM) Market Forecasts to 2030 - Global Analysis By Image Type (3D images and 2D images), Technology (Temporal Subtraction, Dual Energy CEDM and Other Technologies), Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球造影数位乳房X光摄影(CEDM) 市场规模将达到4.6259 亿美元,预计在预测期内将以12.8% 的复合年增长率增长,到2030 年达到9.5291 亿美元。
造影数位乳房X光摄影(CEDM)是一种用于乳癌筛检和诊断的先进影像技术。显影剂注射到患者的血液中,以突出显示乳房病变中的异常血管。这增加了乳房X光摄影中可疑区域的可见度,特别是在传统乳房X光摄影无法得出结论的情况下。 CEDM结合了乳房X光摄影和显影剂增强影像的优点,以提高乳癌检测灵敏度,特别是当乳房组织緻密时。
根据美国乳癌统计数据,美国八分之一的女性(约 12.4%)在一生中会罹患侵袭性乳癌。根据世界卫生组织 (WHO) 的数据,乳癌是女性最常见的癌症,约占亚洲女性癌症的 35%。
省时高效率的流程
数位乳房X光摄影以其快速结果而闻名,您的医生可以立即看到结果。无需像传统工艺那样花费时间冲洗胶片。测试过程中,技术人员可以在电脑萤幕上查看结果。也可以放大或聚焦于特定位置。也可以修改对比度以区分正常和患病的乳房组织。因此,这已成为市场扩张的主要驱动力。
空间解析度降低
数位乳房X光摄影还具有降低空间解析度的能力。透过数位几何放大,投影的钙化影像超出了最低解析度限制。还有一个问题是显示器上的影像放大能力无法替代真正的、更集中的几何放大。结果,这阻碍了市场的扩张。
新技术的出现
由于 CEDM 的技术进步以及政府宣传活动的多项意识提升活动,预计乳癌死亡率将会下降。然而,对于厚乳房,引入造影数位乳房X光摄影将增强癌症诊断。全球乳癌筛检计画的推出和乳癌发生率的上升正在推动市场扩张。
高成本
数位乳房摄影的价格高于使用传统底片的价格。据认为,这笔费用将透过设备改进而减少的拍摄时间来弥补。然而,研究尚未证明检测乳癌有任何益处。此外,与传统的乳房X光摄影相比,显影剂过敏反应的几率较低,辐射剂量较高。造影乳房X光摄影解决方案正在阻碍市场成长,因为乳房 MR 更耗时、更昂贵,而且会让患者感到不舒服。
市场受到 COVID-19 大流行的负面影响。全球大流行大大减少了乳癌筛检、癌症管理就诊和癌症手术。由于多个国家采取封锁措施,以及包括乳房X光摄影X 光摄影系统在内的各种 X 光成像设备的製造和生产延迟,疫情的爆发影响了乳房X光摄影光摄影系统业务的成长。
诊断预计将成为预测期内最大的细分市场
由于影像技术的进步以及对乳癌早期检测的日益重视,造影数乳房X光摄影(CEDM)市场的诊断部分正在经历显着增长。与传统的乳房X光摄影相比,CEDM由于其增强的对比度和改进的病变检测能力而越来越多地在诊断程序中被采用。人们越来越认识到早期诊断的重要性以及对更准确成像方式的需求也推动了对 CEDM 系统的需求。随着患者数量的增加以及医疗保健提供者优先考虑高效的诊断工具,CEDM 市场的诊断领域预计将持续成长。
医院产业预计在预测期内复合年增长率最高
近年来,医院领域的造影数位乳房X光摄影(CEDM)市场经历了显着成长。由于技术的进步和人们对早期乳癌检测重要性的认识不断提高,医院越来越多地实施 CEDM 系统。此外,CEDM 与医院环境的整合使患者能够在同一屋檐下获得全面的乳房摄影服务,从而促进了这一领域的成长。旨在改善乳癌筛检的有利报销政策和政府措施进一步支持医院采用 CEDM。
在预测期内,由于乳癌发生率高且不断增加,预计北美将占据最大的市场占有率。预计推动市场成长的关键因素包括该地区越来越多地采用先进的诊断技术来检测乳房恶性、造影增强数位乳房X光摄影(CEDM)相对于传统MRI技术的优越性、乳癌发病率以及早期检测和预防意识的筛检。
由于私人和政府机构为提供更好的医疗设施所做的各种努力,预计亚太地区在预测期内将呈现最高的复合年增长率。与标准 MRI 相比,造影数位乳房X光摄影(CEDM) 的成本更低,手术时间更短,且该地区乳癌患者数量迅速增加。提供免费癌症筛检的政府计画也推动了该产业的发展。
According to Stratistics MRC, the Global Contrast Enhanced Digital Mammography (CEDM) Market is accounted for $462.59 million in 2024 and is expected to reach $952.91 million by 2030 growing at a CAGR of 12.8% during the forecast period. Contrast-Enhanced Digital Mammography (CEDM) is an advanced imaging technique used in breast cancer screening and diagnosis. It involves the injection of a contrast agent into the patient's bloodstream, which highlights abnormal blood vessels in breast lesions. This enhances the visibility of suspicious areas on mammograms, particularly in cases where traditional mammography may be inconclusive. CEDM combines the benefits of digital mammography with contrast-enhanced imaging, offering improved sensitivity for detecting breast cancer, especially in dense breast tissue.
According to the U.S. Breast Cancer Statistics, about 1 in 8 women in the U.S. (about 12.4%) would develop invasive breast cancer over the course of her lifetime. Breast cancer, which makes up around 35% of all occurrences of female cancer in Asia, is the most frequent cancer among women, according to the World Health Organization.
Time efficient process
A digital mammography is renowned for its quick results, which are available right away for the doctors to review. There is no requirement to spend time on film developing as there would be in a conventional process. During the examination, the technician can see the results on the computer screen. They can also be altered to magnify and concentrate on specific locations. It is also feasible to alter the contrast to distinguish between normal and diseased breast tissues. As a result, this is the main element fueling the market's expansion.
Reduced spatial resolution
Digital mammography also has a function with a lower spatial resolution. The projected calcification images are elevated above the lowest resolution limit by the digital geometric magnification. The fact that the picture magnification power on the monitor is not a substitute for true geometric magnification with better focus is another problem. As a result, this factor is preventing the market from expanding.
Advent of new technology
The death rate from breast cancer is projected to decrease as a result of technological developments in CEDM and several government campaigns to raise awareness. In thick breasts, however, the introduction of contrast-enhanced digital mammography enhances cancer diagnosis. The introduction of breast cancer screening programmes worldwide and the rise in breast cancer prevalence have fuelled the market's expansion.
High cost
The price of a digital mammography is more than one using traditional film. The procedure's time savings would cover this cost for the improved facilities. However, research falls short of demonstrating the advantages of breast cancer detection. Additionally, there is a lower chance of a contrast allergic reaction and a higher radiation dose compared to traditional mammography. Contrast-enhanced mammography solutions are hindering the market's growth because breast MR is more time-consuming, expensive, and uncomfortable for patients.
The market has been adversely affected by the COVID-19 pandemic. Globally, the pandemic led to significant declines in breast cancer screening, cancer management visits, and cancer operations. Due to the lockdown measures in several nations and the delays in manufacturing and production of a wide variety of X-ray imaging devices, including mammography systems, the pandemic epidemic has had an impact on the growth of the business for mammography systems.
The diagnosis segment is expected to be the largest during the forecast period
The diagnosis segment in the Contrast Enhanced Digital Mammography (CEDM) market has witnessed notable growth due to advancements in imaging technology and an increasing emphasis on early detection of breast cancer. CEDM offers enhanced contrast and improved lesion detection capabilities compared to traditional mammography, driving its adoption in diagnostic procedures. Additionally, rising awareness about the importance of early diagnosis and the need for more accurate imaging modalities has spurred demand for CEDM systems. With a growing patient pool and healthcare providers prioritizing efficient diagnostic tools, the diagnosis segment in the CEDM market is poised for continued growth.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospital segment within the Contrast Enhanced Digital Mammography (CEDM) market has witnessed significant growth in recent years. With advancements in technology and increasing awareness about the importance of early detection of breast cancer, hospitals have been increasingly adopting CEDM systems. Additionally, the integration of CEDM into hospital settings provides patients with access to comprehensive breast imaging services under one roof, contributing to the segment's growth. Favourable reimbursement policies and government initiatives aimed at improving breast cancer screening have further propelled the adoption of CEDM in hospitals.
North America is projected to hold the largest market share during the forecast period owing to high prevalence and increase in incidence of breast cancer. Some of the key factors anticipated to propel the market growth include the rising adoption of advanced diagnostic techniques for breast malignancy detection in the region, the superiority of contrast-enhanced digital mammography over the traditional MRI technique, rising incidence of breast cancer, and growing awareness of early detection and screening of breast cancer.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to various initiatives taken by private and government institutions to provide better health care facilities. Low cost of contrast-enhanced digital mammography, quicker procedure time compared to standard MRI, and a sharp increase in the number of breast cancer patients in the area. Government programmes offering free cancer screenings are also propelling the industry.
Key players in the market
Some of the key players in Contrast Enhanced Digital Mammography (CEDM) market include Allengers Medical Systems Limited, Bmi Biomedical International S.R.L., Carestream Health, Gamma Medica, Inc., GE Healthcare, Hologic Inc., Konica Minolta, Inc., Koninklijke Philips N.V., Metaltronica S.p.A, Planmed Oy, Siemens Healthcare GmbH, Toshiba Medical Systems and Villa Systems Medical SpA.
In May 2024, Konica Minolta, Inc. has been actively working to use recycled plastics, which contribute to a recycling-oriented society. Leveraging its know-how of high-functionality recycling, the Company has started supplying recycled plastics derived from used polycarbonate (PC) water bottles through joint development with NEC Platforms, Ltd. (NEC Platforms) for exterior parts of an Aterm home Wi-Fi router manufactured by NEC Platforms.
In November 2023, Toshiba Medical Systems Europe is launching a new 80-row multislice CT scanner, called Aquilion Prime SP, at next week's U.K. Radiological Congress (UKRC) in Manchester. Aquilion Prime SP includes a number of Toshiba technologies designed to meet increasing demands for superior imaging and outstanding economic performance, according to the company. It includes technologies such as Toshiba's PureVision Optics mode, which makes up to 40% more efficient use of x-rays.